Schroder Investment Management Group lessened its position in Cognex Co. (NASDAQ:CGNX) by 37.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 91,202 shares of the scientific and technical instruments company’s stock after selling 55,498 shares during the period. Schroder Investment Management Group owned about 0.11% of Cognex worth $10,033,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. The Manufacturers Life Insurance Company lifted its stake in shares of Cognex by 1.9% in the second quarter. The Manufacturers Life Insurance Company now owns 133,670 shares of the scientific and technical instruments company’s stock worth $11,349,000 after buying an additional 2,551 shares in the last quarter. LMR Partners LLP bought a new position in shares of Cognex in the third quarter worth approximately $8,308,000. DekaBank Deutsche Girozentrale bought a new position in shares of Cognex in the third quarter worth approximately $841,000. Eagle Boston Investment Management Inc. bought a new position in shares of Cognex in the third quarter worth approximately $265,000. Finally, Airain ltd bought a new position in shares of Cognex in the second quarter worth approximately $1,074,000. Hedge funds and other institutional investors own 84.25% of the company’s stock.

Cognex Co. (NASDAQ CGNX) opened at $64.38 on Friday. The firm has a market cap of $10,735.01, a P/E ratio of 45.75 and a beta of 1.50. Cognex Co. has a 52-week low of $31.18 and a 52-week high of $72.99.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Monday, October 30th. The scientific and technical instruments company reported $0.57 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.05. The company had revenue of $259.74 million for the quarter, compared to the consensus estimate of $255.95 million. Cognex had a net margin of 34.77% and a return on equity of 23.31%. The firm’s revenue for the quarter was up 75.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.31 earnings per share. equities analysts forecast that Cognex Co. will post 1.39 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 1st. Investors of record on Friday, November 17th were given a dividend of $0.045 per share. The ex-dividend date was Thursday, November 16th. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. Cognex’s dividend payout ratio (DPR) is 13.28%.

In other Cognex news, CEO Robert Willett sold 100,000 shares of the stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $127.19, for a total value of $12,719,000.00. Following the transaction, the chief executive officer now directly owns 100,000 shares in the company, valued at $12,719,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John J. Curran sold 12,500 shares of the stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $132.60, for a total transaction of $1,657,500.00. Following the completion of the transaction, the insider now owns 6,250 shares in the company, valued at $828,750. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 148,750 shares of company stock worth $19,097,525. 5.60% of the stock is owned by insiders.

CGNX has been the topic of several analyst reports. Zacks Investment Research upgraded shares of Cognex from a “hold” rating to a “buy” rating and set a $69.00 target price on the stock in a research note on Wednesday, November 1st. BidaskClub downgraded shares of Cognex from a “buy” rating to a “hold” rating in a research note on Thursday. Canaccord Genuity upped their target price on shares of Cognex from $47.50 to $60.00 and gave the stock a “hold” rating in a research note on Tuesday, October 31st. Robert W. Baird upped their target price on shares of Cognex from $50.00 to $62.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 31st. Finally, Wolfe Research upgraded shares of Cognex from a “market perform” rating to an “outperform” rating in a research report on Monday, August 14th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $60.17.

ILLEGAL ACTIVITY NOTICE: “Schroder Investment Management Group Has $10.03 Million Stake in Cognex Co. (CGNX)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/09/schroder-investment-management-group-has-10-03-million-stake-in-cognex-co-cgnx.html.

Cognex Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Stock Ratings for Cognex Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Co. and related stocks with our FREE daily email newsletter.